Femasys Inc
FEMY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001339005
In the last 90 days, Femasys Inc insiders filed 5 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $8.65M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Femasys Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 17 | 19 | +2 |
| Shares | 894.1K | 1.07M | +177.8K (+19.9%) |
| Value | $1.01M | $898.3K | −$111.9K (−11.1%) |
New holders (4)
Institutions that held Femasys Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MAI Capital Management | 87,808 | $79.0K | 0.00% |
| HB Wealth Management, LLC | 54,468 | $49.0K | 0.00% |
| Coppell Advisory Solutions LLC | 36,977 | – | – |
| Coppell Advisory Solutions Corp. | 36,977 | – | – |
Sold out (2)
Institutions that held Femasys Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Oppenheimer & Co Inc | 19,088 | $22.0K |
| Goldman Sachs Group Inc | 13,234 | $15.0K |